4.2 Article

Usability of intravenous thiamine injection test compared with odor stick identification test for Japanese patients with severe traumatic brain injury

Journal

AURIS NASUS LARYNX
Volume 47, Issue 2, Pages 233-237

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.anl.2019.07.004

Keywords

Olfactory dysfunction; Intravenous thiamine injection; OSIT-J; Traumatic brain injury; Traumatic smell dysfunction

Funding

  1. Rehabilitation Center for Traumatic Apallics Chiba, National Agency for Automotive Safety and Victims' Aid

Ask authors/readers for more resources

Objective: Olfactory dysfunction is often observed after severe traumatic brain injury (sTBI). Its diagnosis is difficult because patients with sTBI have a communication disability following impaired consciousness and communication disorder. The intravenous thiamine injection (IT) test is one of the representative diagnostic examinations to identify dysfunction, and it is often used in medical certification for liability insurance of automobiles in Japan because it could be judged by a simple reaction. However, the extent of usefulness of the IT test in the diagnosis of olfactory dysfunction in patients with sTBI is unknown. In this study, we validated the usability of the IT test and compared the results with those of the odor stick identification test for the Japanese (OSIT-J) to evaluate the sensitivity of the IT test in patients with sTBI. Methods: The study enrolled 205 subjects, including 10 healthy volunteers and 195 patients with sTBI. First, we examined olfactory dysfunction in sTBI patients using OSIT-J. Subsequently, we performed the IT test among patients with olfactory dysfunction. Results: In the first part, 41 subjects, including 10 healthy volunteers, were examined by using the OSIT-J test. As a result, 28 patients were diagnosed with olfactory dysfunction (90.3%, p < 0.0001), including anosmia and parosmia, compared with healthy volunteers. Among the 12 odors, garlic odor was easily recognized for patients with olfactory dysfunction. As a consequence of the IT test for 11 patients with olfactory dysfunction, four patients recognized thiamine odor, and seven patients did not. All four patients could recognize the garlic odor of OSIT-J, but 2 of the seven patients could recognize the garlic odor of OSIT-J, suggesting that the thiamine odor is linked to garlic odor (p = 0.046), but not always. The detection rate of olfactory dysfunction through the IT test was 36.4%. Conclusion: Our data showed that garlic odor, which is similar to thiamine odor, was easily recognizable for patients with sTBI. However, the IT test might overlook the diagnosis of olfactory dysfunction because it only identifies one odor. In addition, thiamine frequently induces angialgia. We should pay attention to the overconfidence of the IT test for patients with sTBI. (C) 2019 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma

Elias A. El-Habr, Luiz G. Dubois, Fanny Burel-Vandenbos, Alexandra Bogeas, Joanna Lipecka, Laurent Turchi, FranOois-Xavier Lejeune, Paulo Lucas Cerqueira Coehlo, Tomohiro Yamaki, Bryan M. Wittmann, Mohamed Fareh, Emna Mahfoudhi, Maxime Janin, Ashwin Narayanan, Ghislaine Morvan-Dubois, Charlotte Schmitt, Maite Verreault, Lisa Oliver, Ariane Sharif, Johan Pallud, Bertrand Devaux, Stephanie Puget, Penelope Korkolopoulou, Pascale Varlet, Chris Ottolenghi, Isabelle Plo, Vivaldo Moura-Neto, Thierry Virolle, Herve Chneiweiss, Marie-Pierre Junier

ACTA NEUROPATHOLOGICA (2017)

Article Clinical Neurology

Increased brain glucose metabolism in chronic severe traumatic brain injury as determined by longitudinal 18F-FDG PET/CT

Tomohiro Yamaki, Yoshio Uchino, Haruko Henmi, Mizuho Kamezawa, Miyoko Hayakawa, Tomoki Uchida, Yoshihiro Ozaki, Shinji Onodera, Nobuo Oka, Masaru Odaki, Daisuke Itou, Shigeki Kobayashi

JOURNAL OF CLINICAL NEUROSCIENCE (2018)

Article Multidisciplinary Sciences

Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma

Tomohiro Yamaki, Yusuke Suenaga, Toshihiko Iuchi, Jennifer Alagu, Atsushi Takatori, Makiko Itami, Akinobu Araki, Miki Ohira, Masahiro Inoue, Hajime Kageyama, Sana Yokoi, Naokatsu Saeki, Akira Nakagawara

SCIENTIFIC REPORTS (2013)

Article Multidisciplinary Sciences

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury

Tomohiro Yamaki, Shinji Onodera, Tomoki Uchida, Yoshihiro Ozaki, Kazuaki Yokoyama, Haruko Henmi, Mizuho Kamezawa, Miyoko Hayakawa, Daisuke Itou, Nobuo Oka, Masaru Odaki, Yasuo Iwadate, Shigeki Kobayashi

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)

Article Multidisciplinary Sciences

Oncological and functional outcomes of supratotal resection of IDH1 wild-type glioblastoma based on 11C-methionine PET: a retrospective, single-center study

Seiichiro Hirono, Ko Ozaki, Masayoshi Kobayashi, Ayaka Hara, Tomohiro Yamaki, Tomoo Matsutani, Yasuo Iwadate

Summary: In this study comparing SupTR and GTR in GBM patients, it was found that SupTR led to improved local control and survival without postoperative neurocognitive decline. The different patterns of disease progression and distant recurrences observed in the SupTR group highlight the benefits of aggressive resection of both CE tumors and areas with Met uptake, especially under awake craniotomy with functional mapping.

SCIENTIFIC REPORTS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

The role of optimal cut-off diagnosis in 11C-methionine PET for differentiation of intracranial brain tumor from non-neoplastic lesions before treatment

Tomohiro Yamaki, Yoshinori Higuchi, Hajime Yokota, Yasuo Iwadate, Tomoo Matsutani, Seiichiro Hirono, Hikaru Sasaki, Ryota Sasao, Masahiro Toda, Shinji Onodera, Nobuo Oka, Shigeki Kobayashi

Summary: The study investigated the role of 11C-METPET in differentiating brain tumors from non-neoplastic lesions. The use of optimal cutoff values showed high specificity, indicating a high likelihood of brain tumor.

CLINICAL IMAGING (2022)

Article Neurosciences

Prediction of voluntary movements of the upper extremities by resting state-brain regional glucose metabolism in patients with chronic severe brain injury: A pilot study

Tomohiro Yamaki, Naoya Hatakeyama, Takemi Murayama, Mika Funakura, Takuya Hara, Shinji Onodera, Daisuke Ito, Maidinamu Yakufujiang, Masaru Odaki, Nobuo Oka, Shigeki Kobayashi

Summary: In this pilot study, the researchers investigated whether assessing regional brain glucose metabolism using FDG-PET at rest could predict voluntary movement in severe TBI patients, particularly those with sufficient upper limb capacity. The results showed that glucose uptake in specific areas of the primary motor cortex may reflect contralateral voluntary movement. FDG-PET may be a useful biomarker for predicting long-term recovery of motor function in severe TBI patients with disorders of consciousness.

HUMAN BRAIN MAPPING (2023)

Review Clinical Neurology

Scoping Review on the Diagnosis, Prognosis, and Treatment of Pediatric Disorders of Consciousness

Erika Molteni, Liane dos Santos Canas, Marie-Michele Briand, Anna Estraneo, Carolina Colomer Font, Rita Formisano, Ekaterina Fufaeva, Olivia A. Gosseries, Robyn Howarth, Paola Lanteri, Gimena Ines L. Licandro, Wendy Magee, Vigneswaran Veeramuthu, Pamela Wilson, Tomohiro S. Yamaki, Beth Slomine

Summary: Comprehensive guidelines for the diagnosis, prognosis, and treatment of disorders of consciousness (DoC) in pediatric patients have not yet been released. This scoping review aimed to summarize available evidence for DoC with >14 days duration to support the future development of guidelines for children, adolescents and young adults aged 6 months-18 years.

NEUROLOGY (2023)

Article Medicine, General & Internal

Longitudinal CT evaluation of transdermal scopolamine for aspiration pneumonia with sialorrhea in severe chronic brain injury: A case series

Tomohiro Yamaki, Kyoko Takahashi, Osamu Azuhata, Daisuke Itou, Madinum Yakufujiang, Nobuo Oka, Masaru Odaki, Shigeki Kobayashi

Summary: This study presents four cases of severe chronic brain injury patients who suffered from recurrent aspiration pneumonia due to excessive saliva production. Transdermal scopolamine, applied as a patch, was found to decrease pleural effusion associated with continuous aspiration pneumonia in all four cases, as shown in longitudinal computed tomography.

SAGE OPEN MEDICAL CASE REPORTS (2022)

Article Psychiatry

Association between uncooperativeness and the glucose metabolism of patients with chronic behavioral disorders after severe traumatic brain injury: a cross-sectional retrospective study

Tomohiro Yamaki, Kosuke Suzuki, Yusuke Sudo, Tomihisa Niitsu, Masahiko Okai, Nobuo Oka, Masaru Odaki

BIOPSYCHOSOCIAL MEDICINE (2018)

Meeting Abstract Neurosciences

Smell disorder in chronic severe traumatic head injury patients

Tomohiro Yamaki, Yoshio Uchino, Masahiko Okai, Nobuo Oka, Masaru Odaki

BRAIN INJURY (2017)

Article Oncology

Hypofractionated high-dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT

T Iuchi, K Hatano, Y Narita, T Kodama, T Yamaki, K Osato

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)

Article Health Care Sciences & Services

Intravenous Infusion of Autoserum-Expanded Autologous Mesenchymal Stem Cells in Patients With Chronic Brain Injury: Protocol for a Phase 2 Trial

Shinichi Oka, Tomohiro Yamaki, Masanori Sasaki, Ryo Ukai, Mitsuhiro Takemura, Takahiro Yokoyama, Yuko Kataoka-Sasaki, Rie Onodera, Yoichi M. Ito, Shigeki Kobayashi, Jeffery D. Kocsis, Yasuo Iwadate, Osamu Honmou

Summary: This study aims to evaluate the safety and potential efficacy of autologous MSCs intravenous infusion for patients with chronic brain injury. The use of STR-01 has shown promising results in other diseases, and assessing its therapeutic efficacy for chronic brain injury is essential. This research is crucial in exploring potential treatments for brain injuries.

JMIR RESEARCH PROTOCOLS (2022)

No Data Available